Considerations on Regulatory Science and Pharmaceutical Research for Adenovirus Vector Vaccine Platform Technology

Li Xiaojing, Li Changgui, Li Min, Wang Tao

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (3) : 247-258.

PDF(1017 KB)
PDF(1017 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (3) : 247-258. DOI: 10.16153/j.1002-7777.2025-11-0007
Supervision & Administration

Considerations on Regulatory Science and Pharmaceutical Research for Adenovirus Vector Vaccine Platform Technology

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(3): 247-258 https://doi.org/10.16153/j.1002-7777.2025-11-0007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1017 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉